The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Venetoclax (VEN) and tyrosine kinase inhibitor (TKI) combinations in Philadelphia chromosome-positive (Ph+) acute myeloid leukemia (AML) and chronic myeloid leukemia myeloid blast phase (CML MBP).
 
Abhishek Maiti
Research Funding - Celgene (Inst)
 
Farhad Ravandi
No Relationships to Disclose
 
Jorge E. Cortes
Consulting or Advisory Role - Amphivena Therapeutics; Astellas Pharma; Bio-Path Holdings, Inc; BiolineRx; Bristol-Myers Squibb; Daiichi Sankyo; Jazz Pharmaceuticals; Novartis; Pfizer; Takeda
Research Funding - Arog (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Celator (Inst); Celgene (Inst); Daiichi Sankyo (Inst); Immunogen (Inst); Merus (Inst); Novartis (Inst); Pfizer (Inst); Sun Pharma (Inst); Takeda (Inst); Tolero Pharmaceuticals (Inst); Trovagene (Inst)
 
Elias Jabbour
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; Amgen; Astellas Pharma; Bristol-Myers Squibb; Incyte; Pfizer; Takeda
Research Funding - Abbvie; Adaptive Biotechnologies; Amgen; Pfizer; Takeda
 
Kayleigh Marx
No Relationships to Disclose
 
Naval Guastad Daver
Consulting or Advisory Role - Abbvie; Agios; Astellas Pharma; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Jazz Pharmaceuticals; Novartis; Pfizer
Research Funding - Abbvie; Astellas Pharma; Bristol-Myers Squibb; Daiichi Sankyo; Genentech; Immunogen; Nohla Therapeutics; Pfizer; Servier
 
Guillermo Garcia-Manero
Honoraria - Abbvie; Acceleron Pharma; Astex Pharmaceuticals; Celgene; Helsinn Healthcare
Consulting or Advisory Role - Acceleron Pharma; Astex Pharmaceuticals; Celgene; Jazz Pharmaceuticals
Research Funding - Astex Pharmaceuticals; celgene
 
Marina Konopleva
Stock and Other Ownership Interests - Reata Pharmaceuticals
Honoraria - Abbvie; Calithera Biosciences; Genentech
Consulting or Advisory Role - AbbVie; Cellectis; Genentech/Roche; Stemline Therapeutics
Research Funding - Abbvie (Inst); Ablynx (Inst); Calithera Biosciences (Inst); Cellectis (Inst); Genentech (Inst); Lilly (Inst); Roche (Inst); Stemline Therapeutics (Inst)
 
Christopher Brent Benton
No Relationships to Disclose
 
Lucia Masarova
No Relationships to Disclose
 
Courtney Denton Dinardo
Honoraria - Abbvie; Agios; Bayer; Celgene; Karyopharm Therapeutics; MedImmune
Consulting or Advisory Role - Agios; Celgene
Research Funding - Abbvie; AGIOS; Celgene; Daiichi Sankyo
 
Prithviraj Bose
Honoraria - Incyte
Consulting or Advisory Role - Celgene
Research Funding - Blueprint Medicines (Inst); Celgene (Inst); Celgene (Inst); CTI BioPharma Corp (Inst); Gilead Sciences (Inst); Incyte (Inst); Incyte (Inst); Incyte (Inst); NS Pharma (Inst); Promedior (Inst)
Travel, Accommodations, Expenses - Celgene; Incyte
 
Kiran Naqvi
No Relationships to Disclose
 
Sherry A. Pierce
No Relationships to Disclose
 
Hagop M. Kantarjian
Honoraria - Abbvie; Amgen; ARIAD; Bristol-Myers Squibb; Immunogen; Orsenix; Pfizer
Research Funding - Amgen (Inst); ARIAD (Inst); Astex Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst); Pfizer (Inst)
 
Nicholas James Short
No Relationships to Disclose